Early Clinical Experience with A New Short, Self-Expanding, Transcatheter Aortic Valve: Optimum-TAV

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Grant Support/Research Contract - Abbott; Edwards Lifesciences; Boston Scientific Corporation; Medtronic
• Consultant Fee/Honoraria/Speaker's Bureau - Medtronic
• Equity/Stock(s)/Options - Thubrikar; Microinterventional